Dr. Reddy's Laboratories Ltd. (RDY)
Dr. Reddy's Laboratories Market Cap : 12.28B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 12.28B |
| November 12, 2026 | 12.27B |
| November 11, 2026 | 12.36B |
| November 10, 2026 | 12.38B |
| November 09, 2026 | 12.54B |
| November 06, 2026 | 12.42B |
| November 05, 2026 | 12.10B |
| November 04, 2026 | 12.30B |
| November 03, 2026 | 11.91B |
| November 02, 2026 | 11.77B |
| October 30, 2026 | 11.80B |
| October 29, 2026 | 11.75B |
| October 28, 2026 | 11.79B |
| October 27, 2026 | 11.45B |
| October 26, 2026 | 11.45B |
| October 23, 2026 | 11.00B |
| October 22, 2026 | 11.02B |
| October 21, 2026 | 10.99B |
| October 20, 2026 | 11.05B |
| October 19, 2026 | 10.90B |
| October 16, 2026 | 10.89B |
| October 15, 2026 | 10.75B |
| October 14, 2026 | 10.62B |
| October 13, 2026 | 10.64B |
| October 12, 2026 | 10.68B |
| Date | Value |
|---|---|
| October 09, 2026 | 10.40B |
| October 08, 2026 | 10.16B |
| October 07, 2026 | 10.22B |
| October 06, 2026 | 10.40B |
| October 05, 2026 | 10.26B |
| October 02, 2026 | 10.20B |
| October 01, 2026 | 10.20B |
| September 30, 2026 | 10.51B |
| September 29, 2026 | 10.70B |
| September 28, 2026 | 10.42B |
| September 25, 2026 | 10.20B |
| September 24, 2026 | 10.25B |
| September 23, 2026 | 10.32B |
| September 22, 2026 | 10.47B |
| September 21, 2026 | 10.33B |
| September 18, 2026 | 10.15B |
| September 17, 2026 | 10.15B |
| September 16, 2026 | 9.729B |
| September 15, 2026 | 9.621B |
| September 14, 2026 | 9.921B |
| September 11, 2026 | 9.913B |
| September 10, 2026 | 9.754B |
| September 09, 2026 | 9.896B |
| September 08, 2026 | 9.896B |
| September 04, 2026 | 9.971B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 68.47B |
| Teva Pharmaceutical Industries Ltd. | 51.93B |
| AstraZeneca PLC | 572.10B |
| ANI Pharmaceuticals, Inc. | 1.636B |
| Corcept Therapeutics, Inc. | 7.977B |
Market Cap Related Metrics
| PE Ratio | 40.51 |
| PS Ratio | 3.451 |
| Price to Book Value | 3.047 |
| Price to Free Cash Flow | 398.34 |
| Price | 14.74 |
| Earnings Yield | 2.47% |
| Operating PE Ratio | 38.57 |
| Normalized PE Ratio | 39.77 |